Improving Type 2 Diabetes Care with Extended-Release Metformin: Real-Life Insights from a Physician Educational Program.
Molteni L, Marelli G, Castagna G, Brambilla L, Acerbis M, Alberghina F, Carpani A, Chiavenna E, Ferlini MG, Impellizzeri C, Paredi R, Rigamonti A, Rivolta G, Disoteo OE.
Molteni L, et al. Among authors: castagna g.
Endocr Metab Immune Disord Drug Targets. 2024;24(12):1422-1430. doi: 10.2174/0118715303294909240221102552.
Endocr Metab Immune Disord Drug Targets. 2024.
PMID: 38425116
Free PMC article.